Clene Inc. - Common Stock (NQ:CLNN)

4.080 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Clene Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Clene's Neurogenerative Candidate Shows Potential For Improved Long-Term Survival ↗

September 25, 2023

Clene Inc. (NASDAQ: CLNN) released long-term follow-up data for patients treated with CNM-Au8 30mg for up to 133 weeks in the

Via Benzinga

InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) Releases Significant Long-Term Survival Improvement Data from ALS Trial

September 25, 2023

Via Investor Brand Network

Expert Ratings for Clene ↗

September 21, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

September 08, 2023

Via Benzinga

Where Clene Stands With Analysts ↗

August 14, 2023

Via Benzinga

Why Clene Shares Are Nosediving ↗

June 16, 2023

Clene Inc. (NASDAQ: CLNN) shares are trading lower by 13.81% to $0.90 Friday morning after the company announced pricing of a $40 million public offering.

Via Benzinga

Where Clene Stands With Analysts ↗

June 16, 2023

Via Benzinga

Expert Ratings for Clene ↗

May 16, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

August 25, 2023

Via Benzinga

Clene And 2 Other Stocks Under $3 Insiders Are Aggressively Buying ↗

June 28, 2023

The Dow Jones closed higher by over 200 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

BioMedNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces $40M Public Offering

June 22, 2023

Via Investor Brand Network

Uber To Rally Around 55%? Here Are 10 Other Analyst Forecasts For Wednesday ↗

June 21, 2023

Rosenblatt boosted the price target for Lumentum Holdings Inc. (NASDAQ: LITE) from $48 to $67. Rosenblatt analyst Mike Genovese maintained a Neutral rating. Lumentum shares fell 1.3% to $60.56 in...

Via Benzinga

Clene: Q1 Earnings Insights ↗

May 12, 2023

Via Benzinga

Analyst Expectations for Clene's Future ↗

April 26, 2023

Via Benzinga

Analyst Ratings for Clene ↗

April 10, 2023

Via Benzinga

Clene's Return On Capital Employed Overview ↗

March 15, 2023

Via Benzinga

Nasdaq Down 80 Points; US Consumer Sentiment Surges To 4-Month High In June ↗

June 16, 2023

U.S. stocks traded lower toward the end of trading, with Nasdaq Compsoite dropping around 80 points on Friday. The Dow traded down 0.24% to 34,324.18 while the NASDAQ fell 0.59% to 13,701.06. The S&P...

Via Benzinga

Clene's CNM-Au8 Shows Significant Reduction In Neurodegenerative Biomarker, Raises $40M Via Equity ↗

June 16, 2023

Clene Inc (NASDAQ: CLNN) reported new data demonstrating a statistically significant reduction of plasma neurofilament light chain (NfL) levels for CNM-Au8 treated participants compared to placebo...

Via Benzinga

Why Squarespace Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

June 16, 2023

Gainers Oncorus, Inc. (NASDAQ: ONCR) shares surged 258% to $0.2781.

Via Benzinga

The Latest Analyst Ratings for Clene ↗

March 10, 2023

Via Benzinga

Crude Oil Rises; Adobe Posts Upbeat Results ↗

June 16, 2023

U.S. stocks traded slightly higher midway through trading, with Dow Jones gaining around 20 points on Friday. The Dow traded up 0.06% to 34,428.13 while the NASDAQ rose 0.05% to 13,789.23. The S&P 500,...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

June 16, 2023

Via Benzinga

Why Clene Shares Are Trading Lower By 20%; Here Are 20 Stocks Moving Premarket ↗

June 16, 2023

Gainers Evelo Biosciences, Inc. (NASDAQ: EVLO) shares gained 192.8% to $0.2427 in pre-market trading. Evelo Biosciences was granted U.S. patent #11672834 for "Prebiotic Compositions And Methods Of Use...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

June 09, 2023

Via Benzinga

Gilead Sciences To Rally Around 28%? Here Are 10 Other Analyst Forecasts For Tuesday ↗

May 16, 2023

Morgan Stanley raised the price target for DraftKings Inc. (NASDAQ: DKNG) from $23 to $25. Morgan Stanley analyst Stephen Grambling maintained an Overweight rating. DraftKings shares fell 0.2% to close...

Via Benzinga

Valero Energy To Rally 32%? Here Are 10 Other Analyst Forecasts For Monday ↗

April 10, 2023

Credit Suisse boosted the price target for The Boeing Company (NYSE: BA) from $200 to $220. Credit Suisse analyst Scott Deuschle maintained a Neutral rating on the stock. Boeing shares fell 0.4% to...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

March 09, 2023

It's time for another breakdown of the biggest pre-market stock movers traders will want to know about on Thursday morning!

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 08, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2023 ↗

March 08, 2023

Via Benzinga

Clene's Lead Amyotrophic Lateral Sclerosis Shows Improved Function, Slowed Disease Progression ↗

March 06, 2023

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.